The Journal of Experimental Medicine
VeriKine-HS Human IFN-Beta
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 181K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cogswell, P. C.
Right arrow Articles by Baldwin, A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cogswell, P. C.
Right arrow Articles by Baldwin, A. S., Jr.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/1997/2/491/ $5.00
The Journal of Experimental Medicine, Volume 185, Number 3, February 3, 1997 491-498

Articles

Involvement of Egr-1/RelA Synergy in Distinguishing T Cell Activation from Tumor Necrosis Factor-{alpha}–induced NF-{kappa}B1 Transcription

Patricia C. Cogswell*, Marty W. Mayo*, and Albert S. Baldwin, Jr.*,{ddagger}

From the * Lineberger Comprehensive Cancer Center, and {ddagger} Department of Biology, University of North Carolina, Chapel Hill, North Carolina 27599-7295

NF-{kappa}B is an important transcription factor required for T cell proliferation and other immunological functions. The NF-{kappa}B1 gene encodes a 105-kD protein that is the precursor of the p50 component of NF-{kappa}B. Previously, we and others have demonstrated that NF-{kappa}B regulates the NF-{kappa}B1 gene. In this manuscript we have investigated the molecular mechanisms by which T cell lines stimulated with phorbol 12-myristate 13-acetate (PMA) and phytohemagglutin (PHA) display significantly higher levels of NF-{kappa}B1 encoding transcripts than cells stimulated with tumor necrosis factor-{alpha}, despite the fact that both stimuli activate NF-{kappa}B. Characterization of the NF-{kappa}B1 promoter identified an Egr-1 site which was found to be essential for both the PMA/ PHA-mediated induction as well as the synergistic activation observed after the expression of the RelA subunit of NF-{kappa}B and Egr-1. Furthermore, Egr-1 induction was required for endogenous NF-{kappa}B1 gene expression, since PMA/PHA-stimulated T cell lines expressing antisense Egr-1 RNA were inhibited in their ability to upregulate NF-{kappa}B1 transcription. Our studies indicate that transcriptional synergy mediated by activation of both Egr-1 and NF-{kappa}B may have important ramifications in T cell development by upregulating NF-{kappa}B1 gene expression.

Address correspondence to Albert S. Baldwin, Lineberger Comprehensive Cancer Center, Campus Box No. 7295, University of North Carolina, Chapel Hill, NC 27599.

This work was funded by the National Institute of Health (NIH) grant AI35098 awarded to A.S Baldwin and by the NIH postdoctoral fellowship grant 1F32-CA69790-01 awarded to M.W. Mayo.

1Abbreviations used in this paper: Egr-1; early growth response gene product; EMSA, electrophoretic mobility shift assay.

P.C. Cogswell and M.W. Mayo contributed equally to the scientific merit and preparation of this manuscript.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS